Literature DB >> 18690881

Validating diagnostic tests, correct and incorrect methods, new developments.

Ton J Cleophas1, Jolanda Droogendijk, Bas M van Ouwerkerk.   

Abstract

BACKGROUND: Clinical developments of new treatments are impossible without adequate diagnostic tests. Several working parties including the Consolidated Standard Randomized Trials (CONSORT) movement and the Standard for Reporting Diagnostic Accuracy (STARD) group have launched quality criteria for diagnostic tests. Particularly, accuracy-, reproducibility- and precision-assessments have been recommended, but methods of assessment have not been defined so far.
OBJECTIVE: To summarize correct and incorrect methods and new developments for that purpose. RESULTS AND
CONCLUSIONS: A diagnostic test can be either qualitative like the presence of an elevated erythrocyte sedimentation rate to demonstrate pneumonia, or quantitative like ultrasound flow velocity to estimate invasive electromagnetic flow velocity. Qualitative diagnostic tests can be assessed for -accuracy using sensitivity / specificity / overall accuracy, and receiver operated (ROC) curves, -reproducibility using Cohen's kappas, -precision using confidence intervals of sensitivity / specificity / overall accuracy. Quantitative diagnostics tests can be assessed for -accuracy using a linear regression line (y = a + b x) and testing a = 0.00 / b = 1.00, -reproducibility using duplicate standard errors, repeatability coefficients or intraclass correlations, -precision by calculating confidence intervals. Improved confidence intervals can be obtained by data modeling. A significant linear correlation between the diagnostic test and the gold standard test does not correctly indicate adequate accuracy. A small mean difference between repeated measures or a significant linear relationship between repeated measures does not indicate adequate reproducibility. New developments include continuous ROC curves, intraclass correlations, and Bland-Altman agreement tests for the accuracy assessments of quantitative diagnostic tests.

Entities:  

Mesh:

Year:  2008        PMID: 18690881     DOI: 10.2174/157488408784293697

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  3 in total

1.  ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research.

Authors:  Nanyi Wang; Lirong Wang; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2017-10-26       Impact factor: 4.956

2.  Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method.

Authors:  Ming-Feng Xia; Hong-Mei Yan; Wan-Yuan He; Xiao-Ming Li; Chao-Lun Li; Xiu-Zhong Yao; Ruo-Kun Li; Meng-Su Zeng; Xin Gao
Journal:  Obesity (Silver Spring)       Date:  2011-10-20       Impact factor: 5.002

3.  Association of [1H]-MRS quantified liver fat content with glucose metabolism status.

Authors:  Yun-Sheng Wang; Jun Ye; Yong-Hong Cao; Rong Zhang; Xiao-Fang Han; Ling-Ling Zou; Lei Kuang; Ji Zhang; Hu Lian; Jin-Xiang Xia; Qiu Zhang; Wu Dai
Journal:  Diabetol Metab Syndr       Date:  2020-06-08       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.